financetom
Business
financetom
/
Business
/
Chinese EV giant BYD launches new version of e2 hatchback with lower starting price
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Chinese EV giant BYD launches new version of e2 hatchback with lower starting price
Mar 12, 2024 7:00 PM

BEIJING (Reuters) - Chinese electric vehicle giant BYD on Wednesday launched a new version of e2 EV hatchback with a lower starting price than its predecessor.

The model now starts at 89,800 yuan ($12,507), 12.7% lower than the previous version, Reuters calculations showed.

($1 = 7.1800 Chinese yuan)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Market Chatter: Meta Selects Pacific Investment for $26 Billion Debt Funding Deal
Market Chatter: Meta Selects Pacific Investment for $26 Billion Debt Funding Deal
Sep 8, 2025
07:37 AM EDT, 09/08/2025 (MT Newswires) -- Meta Platforms ( META ) has selected Pacific Investment Management to lead a $26 billion debt financing to construct a new data center in Louisiana, Bloomberg reported Saturday, citing sources familiar with the matter. Blue Owl Capital (OWL) will contribute $3 billion in equity to a joint venture that will build and own...
Top Premarket Gainers
Top Premarket Gainers
Sep 8, 2025
07:36 AM EDT, 09/08/2025 (MT Newswires) -- Rapport Therapeutics ( RAPP ) shares were 165% higher pre-bell Monday after the company said that a phase 2a trial of RAP-219 in patients with drug-resistant focal onset seizures met its primary endpoint. Forward Industries ( FORD ) stock was up 102% after the company said it has secured $1.65 billion for its...
Pfizer, BioNTech Report Positive Preliminary Data From Phase 3 Study for Adapted COVID Vaccine
Pfizer, BioNTech Report Positive Preliminary Data From Phase 3 Study for Adapted COVID Vaccine
Sep 8, 2025
07:36 AM EDT, 09/08/2025 (MT Newswires) -- Pfizer ( PFE ) and BioNTech (BNTX) said Monday that preliminary data from a phase 3 study of their LP.8.1-adapted COVID-19 vaccine, Comirnaty, showed a robust immune response. The cohort included 50 adults aged 65 and older and 50 adults aged 18-64 with at least one underlying risk factor for severe COVID-19. All...
BRIEF-Pharmacorp to Acquire Ontario Pharmacy, Eyes Two More in East Canada; Q2 Update Released
BRIEF-Pharmacorp to Acquire Ontario Pharmacy, Eyes Two More in East Canada; Q2 Update Released
Sep 8, 2025
Sept 8 (Reuters) - PharmaCorp Rx Inc: * PHARMACORP TO ACQUIRE A PHARMACY IN ONTARIO FOR $5,300,000, NEW NON-BINDING LETTER OF INTENT TO ACQUIRE TWO PHARMACIES IN EASTERN CANADA, UPDATES ON PREVIOUSLY ANNOUNCED NON-BINDING LETTERS OF INTENT AND FILING OF Q2 INVESTOR PRESENTATION Source text: Further company coverage: ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved